Monitoring human cytomegalovirus infection in transplant recipients

Journal of Clinical Virology

Volumn 41, Issue 3, 2008, Pages 237-241

  Baldanti, Fausto ^a   Lilleri, Daniele ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cytomegalovirus; Drug resistance; Hemopoietic stem cell transplantation; Immunity; Monitoring; Solid organ transplantation

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HUMAN; LEUKOCYTE; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRAL GENETICS; VIREMIA; VIRUS ISOLATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ORGAN TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; T-LYMPHOCYTES; VIREMIA;

EID: 39149085336     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.12.001     Document Type: Article

References (41)

1. Alain S., Honderlick P., Grenet D., Stern M., Vadam C., Sanson-Le Pors M.J., et al. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation 63 (1997) 1533-1536
2. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., et al. Phenotypic analysis of antigen-specific T-lymphocytes. Science 274 (1996) 94-96
3. Baldanti F., Lilleri D., Campanini G., Comolli G., Ridolfo A.L., Rusconi S., et al. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response. J Antimicrob Chemother 53 (2004) 536-539
4. Baldanti F., Lurain N., and Gerna G. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol 65 (2004) 403-409
5. Baldanti F., Simoncini L., Sarasini A., Zavattoni M., Grossi P., Revello M.G., et al. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation 66 (1998) 324-329
6. Benz C., Holz G., Michel D., Awerkiew S., Dries V., Stippel D., et al. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatic-renal transplant recipient. Transplantation 75 (2003) 724-727
7. Bhorade S.M., Lurain N.S., Jordan A., Leischner J., Villanueva J., Durazo R., et al. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant 21 (2002) 1274-1282
8. Boivin G., Goyette N., Gilbert C., and Covington E. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis. J Med Virol 77 (2005) 425-429
9. Boivin G., Goyette N., Gilbert C., Humar A., and Covington E. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients. Transplant Infect Dis 7 (2005) 166-170
10. Comoli P., Maccario R., Locatelli F., Grossi P., Baldanti F., Revello M.G., et al. Adoptive Transfer of herpesvirus specific cytotoxic T lymphocytes in transplant recipients. Herpes 7 (2000) 9-12
11. Gerna G., Baldanti F., Sarasini A., Furione M., Percivalle E., Revello M.G., et al. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group. Antimicrob Agents Chemother 38 (1994) 38-44
12. Gerna G., Baldanti F., Torsellini M., Minoli L., Viganò M., Oggionni T., et al. Evaluation of cytomegalovirus DNAemia versus pp65-antigenemia cut-off for guiding preemptive therapy in transplant recipients: a randomized study. Antivir Ther 12 (2007) 63-72
13. Gerna G., Lilleri D., Baldanti F., Torsellini M., Giorgiani G., Zecca M., et al. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. Blood 101 (2003) 5053-5060
14. + T-cell immunity in patients receiving solid organ transplantation. Am J Transplant 6 (2006) 2356-2364
15. Gerna G., Lilleri D., Zecca M., Alessandrino E.P., Baldanti F., Revello M.G., et al. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Haematologica 90 (2005) 526-533
16. Gerna G., Percivalle E., Baldanti F., Sozzani S., Lanzarini P., Genini E., et al. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 754 (2000) 629-638
17. + T cells. J Gen Virol 86 (2005) 275-284
18. Gerna G., Percivalle E., Torsellini M., and Revello M.G. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol 36 (1998) 3585-3589
19. Gerna G., Revello M.G., Percivalle E., and Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30 (1992) 1232-1237
20. Gerna G., Revello M.G., Percivalle E., Zavattoni M., Parea M., and Battaglia M. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 28 (1990) 2681-2688
21. Gerna G., Sarasini A., Lilleri D., Percivalle E., Torsellini M., Baldanti F., et al. In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients. J Infect Dis 188 (2003) 1639-1647
22. Gerna G., Vitulo P., Rovida F., Lilleri D., Pellegrini C., Oggionni T., et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 78 (2006) 408-416
23. Gerna G., Zavattoni M., Baldanti F., Sarasini A., Chezzi L., Grossi P., et al. Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 65 (1998) 1378-1385
24. Gerna G., Zavattoni M., Percivalle E., Grossi P., Torsellini M., and Revello M.G. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection. J Clin Microbiol 36 (1998) 1113-1116
25. Gilbert C., Bestman-Smith J., and Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 5 (2002) 88-114
26. Grossi P., Minoli L., Percivalle E., Irish W., Vigano M., and Gerna G. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 59 (1995) 847-851
27. Hahn G., Revello M.G., Patrone M., Percivalle E., Campanini G., Sarasini A., et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78 (2004) 10023-10033
28. Lilleri D., Baldanti F., Gatti M., Rovida F., Dossena L., De Grazia S., et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J Med Virol 73 (2004) 412-418
29. Lilleri D., Fornara C., Furione M., Zavattoni M., Revello M.G., and Gerna G. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 195 (2007) 1062-1070
30. + T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 108 (2006) 1406-1412
31. Lilleri D., Gerna G., Furione M., Bernardo M.E., Giorgiani G., Telli S., et al. Use of a DNAemia cut-off for monitoring human cytomegalovirus infections reduces the number of preemptively treated children and young adults receiving haematopoietic stem cell transplantation as compared to qualitative pp65-antigenemia. Blood 110 (2007) 2757-2760
32. Limaye A.P., Raghu G., Koelle D.M., Ferrenberg J., Huang M.L., and Boeckh M. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 185 (2002) 20-27
33. Limaye A.P. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis 35 (2002) 866-872
34. + T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 35 (2005) 1795-1804
35. Lurain N.S., Ammons H.C., Kapell K.S., Yeldandi V.V., Garrity E.R., and O'Keefe J.P. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation 62 (1996) 497-502
36. Maecker H.T., Dunn H.S., Suni M.A., Khatamzas E., Pitcher C.J., Bunde T., et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255 (2001) 27-40
37. Revello M.G., Percivalle E., Arbustini E., Pardi R., Sozzani S., and Gerna G. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J Clin Invest 101 (1998) 2686-2692
38. Revello M.G., Percivalle E., Di Matteo A., Morini F., and Gerna G. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J Gen Virol 73 (1992) 437-442
39. Rosen H.R., Benner K.G., Flora K.D., Rabkin J.M., Orloff S.L., Olyaei A., et al. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation 63 (1997) 476-478
40. + T cell frequencies by flow cytometry: evidence for a novel antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99 (1997) 1739-1750
41. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333 (1995) 1038-1044